InvestorsHub Logo
Followers 87
Posts 6746
Boards Moderated 1
Alias Born 09/18/2009

Re: Preciouslife1 post# 40509

Friday, 09/08/2023 3:40:05 AM

Friday, September 08, 2023 3:40:05 AM

Post# of 43094
After reading the article you attached, I can say that I am definitely glad to have had the plaque removed from the artery in my left leg a couple of weeks ago.

But again, we have research doctors at least trying to understand excess deaths, including from vaccine-related myocarditis, but they are unable to appreciate their unintended role in exacerbating these circumstances. They can't be faulted for being unaware of information that is withheld from them.

The researchers accept that the mRNA vaccines produce , "... a small risk of developing myocarditis (inflammation of the heart muscle) in the weeks after getting an mRNA COVID vaccine made by Pfizer-BioNTech or Moderna. However, the risk of myocarditis after having COVID is much higher. A study by the Centers for Disease Control and Prevention reported that males ages 12 to 29 — who have the greatest risk of vaccine complications — were four to eight times more likely to develop myocarditis following a COVID infection than in the three weeks after receiving a dose of vaccine. For males 30 and older, the risk of myocarditis was 28 times higher from COVID than from the vaccine."

your link: https://news.yahoo.com/covid-affects-heart-120521925.html

They note that elevated hypertension is another covid-related indication.

But they don't know how Nuvaxovid may provide better results than the mRNA vaccines. And they certainly don't know how lenz could reduce heart and hypertension-related indications by treating and preventing progression of inflammation that leads to developing these indications.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.